EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY 4.0

Statin use and LDL cholesterol target attainment in people with HIV after European AIDS Clinical Society 2024 guideline updates

Giorgia Carrozzo, Beatrice Caloni, Letizia Oreni, Giacomo Pozza, Maria Vittoria Cossu, Davide Moschese, Valentina Iannone, Maddalena Matone, Valeria Colombo, Andrea Poloni, Stefania Caronni, Anna Lisa Ridolfo und 6 weitere

Nutrition, Metabolism and Cardiovascular Diseases · 2026-12 · 36 (12) · 104881

DOI: 10.1016/j.numecd.2026.104881 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Nutrition, Metabolism and Cardiovascular Diseases, 2026-12. Verfasst von Giorgia Carrozzo und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Luigi Sacco Hospital, ASST Fatebenefratelli Sacco, Milan, Italy. Hauptthemen laut MEDLINE: HIV Infections, Cholesterol, LDL, Dyslipidemias, Hydroxymethylglutaryl-CoA Reductase Inhibitors. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND AIMS: The 2024 EACS guidelines introduced stricter LDL-C targets, emphasizing lipid management in people with HIV (PWH). We aimed to assess changes in statin prescription following the guideline update. METHODS AND RESULTS: This retrospective, single-center study compared PWH aged ≥40 years attending follow-up visits between April 2023-April 2024 (Period 1) and April 2024-April 2025 (Period 2). Lipid-lowering therapy use and LDL-C target attainment were evaluated according to 2024 EACS criteria. A total of 1379 individuals were included in Period 1 and 1191 in Period 2. Median LDL-C decreased from 116 mg/dL (IQR 92-139) to 111 mg/dL (IQR 84-137). Statin use increased from 38% to 49% (aOR 1.47, 95% CI 1.37-1.58; p < 0.0001), with greater use of statin-ezetimibe combination therapy (9% vs 19%, p < 0.0001). LDL-C target attainment remained low (8% vs 10%). In multivariable analysis, individuals of African (aOR 0.39, 95% CI 0.21-0.72; p = 0.003) and Hispanic (aOR 0.35, 95% CI 0.19-0.62; p < 0.001) origin had lower odds of receiving statins compared with Caucasians. CONCLUSIONS: Statin prescription increased after the 2024 guideline update, but LDL-C target attainment remained poor, suggesting incomplete implementation of guideline-recommended lipid management in routine HIV care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsCholesterol, LDLDyslipidemiasHydroxymethylglutaryl-CoA Reductase InhibitorsPractice Guidelines as TopicPractice Patterns, Physicians'Guideline AdherenceHumansFemaleRetrospective StudiesMiddle AgedMaleBiomarkersTreatment OutcomeAdultRisk FactorsTime FactorsDrug Therapy, CombinationHealthcare Disparities

Stichwörter der Autor:innen

Cardiovascular riskDyslipidaemiaEACS guidelinesHealth disparitiesPeople with HIVStatins

Substanzen

Cholesterol, LDLHydroxymethylglutaryl-CoA Reductase InhibitorsBiomarkers

Autor:innen und Institutionen

  • Department of Infectious Diseases, Luigi Sacco Hospital, ASST Fatebenefratelli Sacco, Milan, Italy.
  • Research Center, Italian Association of Hospital Cardiologists (ANMCO), Heart Care Foundation, Florence, Italy.
  • Department of Infectious Diseases, Luigi Sacco Hospital, ASST Fatebenefratelli Sacco, Milan, Italy; Department of Biomedical and Clinical Sciences, Università degli Studi di Milano, Milan, Italy.
  • Department of Infectious Diseases, Luigi Sacco Hospital, ASST Fatebenefratelli Sacco, Milan, Italy; Department of Biomedical and Clinical Sciences, Università degli Studi di Milano, Milan, Italy; Centre for Multidiscipl…
  • Department of Infectious Diseases, Luigi Sacco Hospital, ASST Fatebenefratelli Sacco, Milan, Italy; Department of Biomedical and Clinical Sciences, Università degli Studi di Milano, Milan, Italy. Electronic address: and…

Zitieren

APA

Carrozzo, G., Caloni, B., Oreni, L., Pozza, G., Cossu, M. V., Moschese, D., Iannone, V., Matone, M., Colombo, V., Poloni, A., Caronni, S., Ridolfo, A. L., Gervasoni, C., Maggioni, A. P., Antinori, S., Riva, A., Gori, A., & Giacomelli, A. (2026). Statin use and LDL cholesterol target attainment in people with HIV after European AIDS Clinical Society 2024 guideline updates. Nutrition, Metabolism and Cardiovascular Diseases, 36(12), 104881. https://doi.org/10.1016/j.numecd.2026.104881

Vancouver

Carrozzo G, Caloni B, Oreni L, Pozza G, Cossu MV, Moschese D, et al. Statin use and LDL cholesterol target attainment in people with HIV after European AIDS Clinical Society 2024 guideline updates. Nutrition, Metabolism and Cardiovascular Diseases. 2026;36(12):104881. doi:10.1016/j.numecd.2026.104881

BibTeX
@article{Carrozzo2026,
  author = {Carrozzo, Giorgia and Caloni, Beatrice and Oreni, Letizia and Pozza, Giacomo and Cossu, Maria Vittoria and Moschese, Davide and Iannone, Valentina and Matone, Maddalena and Colombo, Valeria and Poloni, Andrea and Caronni, Stefania and Ridolfo, Anna Lisa and Gervasoni, Cristina and Maggioni, Aldo Pietro and Antinori, Spinello and Riva, Agostino and Gori, Andrea and Giacomelli, Andrea},
  title = {Statin use and LDL cholesterol target attainment in people with HIV after European AIDS Clinical Society 2024 guideline updates},
  journal = {Nutrition, Metabolism and Cardiovascular Diseases},
  year = {2026},
  volume = {36},
  number = {12},
  pages = {104881},
  doi = {10.1016/j.numecd.2026.104881}
}
Kostenlos starten →